4.5 Article

Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission

期刊

NUTRITION
卷 89, 期 -, 页码 -

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.nut.2021.111236

关键词

Ketogenic diet; COVID-19; Cytokine storm syndrome; IL-6; Warburg effect; Hyperglycemia; Aerobic glycolysis; SARS-CoV-2

向作者/读者索取更多资源

The study aimed to investigate the impact of a eucaloric ketogenic diet on mortality, ICU admission, and non-invasive ventilation in hospitalized COVID-19 patients, compared to a standard diet. Results showed significant differences in survival and ICU need between the EKD and standard diet groups, supporting the potential therapeutic role of an EKD in managing COVID-19.
Objectives: Our primary objective was to explore the effect of a eucaloric ketogenic diet (EKD) on mortality, admission to the intensive care unit, and need for non-invasive ventilation in hospitalized patients with COronaVIrus Disease 19 (COVID-19), in comparison to a eucaloric standard diet. Secondary objectives were verification of the safety and feasibility of the diet and its effects on inflammatory parameters, particularly interleukin-6. Methods: The study is a retrospective analysis of 34 patients fed with an EKD in comparison to 68 patients fed with a eucaloric standard diet, selected and matched using propensity scores 1:2 to avoid the confounding effect of interfering variables. Our hypothesis was that an EKD would reduce mortality, admission to the intensive care unit, and need for non-invasive ventilation in patients with COVID-19. Results: The preliminary multivariate analysis showed a statistically significant difference in survival (P = 0.046) and need for the intensive care unit (P = 0.049) for the EKD compared with a eucaloric standard diet. Even considering the EKD start day as a time-dependent variable, the results maintain a positive trend for application of the diet, and it is not possible to reject the null hypothesis (P < 0.05). Interleukin-6 concentrations between t0 and t7 (7 d after the beginning of the diet) in the ketogenic nutrition group show a trend that is almost significant (P = 0.062). The EKD was safe and no adverse events were observed. Conclusions: These results show a possible therapeutic role of an EKD in the clinical management of COVID19. Currently, a prospective controlled randomized trial is running to confirm these preliminary data. (c) 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据